What does the evidence say about Ginger Menstrual Nausea Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Ginger Menstrual Nausea Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Searches, data extraction, and risk of bias assessment were performed independently by two reviewers. [Wu L (2026); evidence level 1] - Overall, the certainty of evidence is low to very low due to high heterogeneity and moderate risk of bias. [Wu L (2026); evidence level 1] - Plant-based treatments may reduce pain associated with primary dysmenorrhea and are probably comparable to conventional drug therapies. [Wu L (2026); evidence level 1] - Primary dysmenorrhea is defined as recurrent, cramp-like lower abdominal pain occurring during menstruation in the absence of underlying pelvic pathology. [Wu L (2026); evidence level 1] - Statistically significant reductions in pain severity, improved cognitive function, and gastrointestinal symptoms were observed. [Lagzian Y (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.